GlassScriptPhysician profile
David A Rebuck
NPI 1689809808
$6,041.10
in general payments reported to CMS, 2019-2025
51 companies · $1,018 in 2025
The $1,018 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $916 · 2020: $447 · 2021: $468 · 2022: $1,168 · 2023: $1,104 · 2024: $920 · 2025: $1,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,942 · Education: $100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,941.97 |
| Education | $100.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $787.99 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $526.48 | 2019-2025 | Provenge |
| Pfizer INC. | $460.01 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $303.57 | 2020-2025 | |
| Tolmar Pharmaceuticals, INC. | $267.85 | 2019-2022 | |
| Janssen Biotech, INC. | $259.24 | 2019-2025 | Erleada |
| Merck Sharp & Dohme LLC | $247.10 | 2020-2024 | Lynparza, Keytruda, Welireg |
| Neotract INC. | $207.58 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $196.78 | 2019-2024 | Xiaflex, Aveed |
| Procept Biorobotics Corporation | $182.99 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Coloplast Corp | $180.82 | 2023-2024 | Porges Coloplast, Speedicath, Coloplast Tfl Drive |
| Blue Earth Diagnostics | $180.53 | 2019-2025 | Posluma |
| Verity Pharmaceuticals INC. | $161.82 | 2022-2025 | Trelstar |
| Astrazeneca Pharmaceuticals LP | $161.80 | 2020-2025 | Lynparza, Imfinzi |
| Abbvie INC. | $160.13 | 2019-2025 |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Rebuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.